Hopefully everyone is looking forward to the new year, whether you’re winding down or ploughing on through. I do hope that 2022 is brighter than its predecessors. This week, we are looking into the future with our “Visions of Tomorrow” feature, where generous contributors share how their ophthalmology work is pushing boundaries of what we would consider possible, and we predict how this may progress the future of ophthalmology – both realistically and hypothetically.

Very best wishes,
Geoffrey Potjewyd, Associate Editor

 
BASIC & TRANSLATIONAL RESEARCH
Visions of Tomorrow
12/09/2021 | Geoffrey Potjewyd
The research of today applied to the world of tomorrow – this is where science fiction and ophthalmology intersect
CORNEA / OCULAR SURFACE
Superior Surface Skills
12/01/2021 | Ivan Mac
Keeping up with technological advances shouldn’t be at the expense of caring for the ocular surface
GLAUCOMA
Two Diseases, One Stone
12/10/2021 | Geoffrey Potjewyd
How can a diabetes drug treat glaucoma, and how does real world data support this hypothesis?
BUSINESS AND INNOVATION
Business in Brief
09/17/2021 | Aleksandra Jones
The latest industry news in under 65 words
 
Webinars: On-Demand

Shining a Light on Dry AMD - How Photobiomodulation is Helping Dry AMD Patients
Available On-Demand

Creating a new standard in ophthalmic surgery visualization
Available On-Demand

Clinical applications of hand-held OCT: Bringing the OCT to the patient and not the patient to the OCT
Available On-Demand

 
Special Promotion
Help us provide better content for you. Take our Readership Survey today!

We are committed to improving our publication and its content based on your valuable feedback. Tell us what you think of The Ophthalmologist in our short survey and you could win a $100 Amazon voucher!

 
Interested in Conferences and Events?

We work with event organizers from all around the world to help bring the ophthalmologic community together, from flagship congresses to intimate meetings that fit around a table. Discover some of the events that we partner with and stay up-to-date with the latest developments.

Find out more